Lucero
Company details
Company name
Lucero
Company type
Micro Enterprise (less than 10 employees and revenues less than 2 MEUR)
Industry sector
Medical
Activity description
Lucero was founded in March 2020 in response to industry needs linked to the implementation of 3D cell cultures in early-stage pharmaceutical drug discovery processes. Their solution aims to tackle key challenges surrounding 3D-cell-culture handling, miniaturization, and assay preparation.
Company website
https://www.lucerobio.com/
Project information
Technology platform
TP-1: Free-space photonic components and systems
Application domain
Biomedical
Project scope
A feasibility study towards the miniaturization of the current configuration of their single-sell manipulation tool, by reducing its size and weight, while keeping the same performance.
ACTPHAST Partners
VUB
Project leader
Dr. Ir. Lien Smeesters (VUB)
Project start
March 2021
Project duration
3 months